52 results on '"Borch-Johnsen K"'
Search Results
2. Cost-effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen-detected Type 2 diabetes: analysis of the ADDITION-UK cluster-randomized controlled trial.
3. Cost‐effectiveness of intensive multifactorial treatment compared with routine care for individuals with screen‐detected Type 2 diabetes: analysis of the ADDITION‐UK cluster‐randomized controlled trial
4. Variation in prescribing of lipid‐lowering medication in primary care is associated with incidence of cardiovascular disease and all‐cause mortality in people with screen‐detected diabetes: findings from theADDITION ‐Denmarktrial
5. Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen‐detected diabetes? Results from the ADDITION‐Europe cluster randomized trial
6. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen-detected diabetes? Findings from the ADDITION-Europe cluster-randomized trial
7. Does early intensive multifactorial treatment reduce total cardiovascular burden in individuals with screen‐detected diabetes? Findings from the ADDITION‐Europe cluster‐randomized trial
8. Cardiorespiratory fitness and physical activity in Luo, Kamba, and Maasai of rural Kenya
9. Diabetes in Greenland and its relationship with urbanization
10. The immune marker soluble urokinase plasminogen activator receptor is associated with new‐onset diabetes in non‐smoking women and men
11. Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study
12. Comparing incident diabetes as defined by fasting plasma glucose or by HbA1c. The AusDiab, Inter99 and DESIR studies
13. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1cThe Danish Inter99 study
14. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
15. Prospective and retrospective recording of severe hypoglycaemia, and assessment of hypoglycaemia awareness in insulin‐treated Type 2 diabetes
16. Socioeconomic factors related to attendance at a Type 2 diabetes screening programme
17. Predictors of future fasting and 2‐h post‐OGTT plasma glucose levels in middle‐aged men and women—the Inter99 study
18. Functional SOCS1 polymorphisms are associated with variation in obesity in whites
19. HLA associations in insulin-dependent diabetes: search for heterogeneity in different groups of patients from a homogeneous population
20. Are lifestyle changes achieved after participation in a screening programme for Type 2 diabetes? The ADDITION Study, Denmark
21. A −243A→G polymorphism upstream of the gene encoding GAD65 associates with lower levels of body mass index and glycaemia in a population‐based sample of 5857 middle‐aged White subjects
22. Studies of associations between the Arg389Gly polymorphism of the β1‐adrenergic receptor gene (ADRB1) and hypertension and obesity in 7677 Danish white subjects
23. Authors’ response
24. Large‐scale study of the −232C > G polymorphism of PCK1 in Type 2 diabetes
25. Frequency and risk factors of severe hypoglycaemia in insulin‐treated Type 2 diabetes: a cross‐sectional survey
26. Large‐scale studies of the Leu72Met polymorphism of the ghrelin gene in relation to the metabolic syndrome and associated quantitative traits
27. Can a screening programme for diabetes be applied to another population?
28. The comparison of venous plasma glucose and whole blood capillary glucose in diagnoses of Type 2 diabetes: a population‐based screening study
29. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion
30. Studies of relationships between variation of the human G protein‐coupled receptor 40 Gene and Type 2 diabetes and insulin release
31. Studies of the Ala/Val98 polymorphism of the hepatocyte nuclear factor‐1α gene and the relationship to β‐cell function during an OGTT in glucose‐tolerant women with and without previous gestational diabetes mellitus
32. Targeted screening for undiagnosed diabetes reduces the number of diagnostic tests. Inter99(8)
33. Comparability of venous and capillary glucose measurements in blood
34. First referral of diabetic patients to a nephrologist
35. Studies of variability in the islet amyloid polypeptide gene in relation to Type 2 diabetes
36. Screening for Type 2 diabetes—should it be now?
37. Is low birth weight a risk factor for the development of diabetic nephropathy in patients with type 1 diabetes? A population-based case-control study
38. IGT and IFG. Time for revision?
39. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60‐year‐old Danes
40. Descriptive epidemiology short reports in Diabetic Medicine – an opportunity to present data with the population as the unit of variation
41. Evidence‐based prevention of cardiovascular disease
42. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus
43. Reduced glomerular size‐ and charge‐selectivity in clinically healthy individuals with microalbuminuria
44. Incidence of Insulin‐dependent Diabetes Mellitus in Age Groups Over 30 years in Denmark
45. Increased prevalence of insulin-treated diabetes mellitus in Funen County, Denmark
46. Sudden Death and Human Insulin: Is There a Link?
47. Genes and environment in the inheritance of morbidity and mortality
48. Natural History of Diabetic Complications: Early Detection and Progression
49. Fourth Annual Meeting of the Anglo‐Danish‐Dutch Diabetes Group
50. The Natural History of Insulin‐Dependent Diabetes Mellitus in Denmark: 1. Long‐term survival with and without late diabetic complications
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.